Startups That Raised Funding in South San Francisco

Assembly Biosciences

Location: -

Funding: Raised to $43.00

Date: 78 days ago

Assembly Biosciences is a clinical-stage biotechnology company developing novel small molecule antivirals targeting chronic hepatitis B and D viruses as well as microbiome-based therapeutics for gastrointestinal diseases.

Denali Therapeutics

Location: South San Francisco, California, USA

Website: denalitherapeutics.com

Funding: Raised to $40.00

Date: 89 days ago

Denali Therapeutics is a clinical-stage biotechnology company developing therapeutics for neurodegenerative diseases by leveraging a proprietary platform to deliver drugs across the blood-brain barrier.

CytomX Therapeutics

Location: -

Funding: Raised to $10.00

Date: 139 days ago

CytomX Therapeutics is a clinical-stage biotechnology company developing conditionally activated antibody therapies (Probody therapeutics) to selectively target cancer cells while minimizing off-target toxicity, with the goal of delivering safer and more effective cancer treatments.

Monte Rosa Therapeutics

Location: -

Funding: Raised to $30.00

Date: 166 days ago

Monte Rosa Therapeutics is a biotechnology company leveraging computational and experimental platforms to discover and develop novel allosteric small-molecule modulators targeting G protein-coupled receptors for diseases with high unmet medical needs.

Monte Rosa Therapeutics

Location: -

Funding: Raised to $34.00

Date: 169 days ago

Monte Rosa Therapeutics is a genomics-driven biotechnology company that leverages advanced computational and machine-learning platforms to design targeted immunotherapies for cancer and other diseases, accelerating drug discovery and development.

Nurix Therapeutics

Location: -

Funding: Raised to $30.00

Date: 195 days ago

Nurix Therapeutics is a biopharmaceutical company developing targeted small-molecule therapies that harness the ubiquitin proteasome system to degrade disease-causing proteins in oncology and immunology.

Senti Biosciences

Location: -

Funding: Raised to $13.00

Date: 199 days ago

Senti Biosciences is a clinical-stage synthetic biology company that engineers programmable gene circuits to develop targeted cell therapies for treating complex diseases.

Olema Pharmaceuticals

Location: -

Funding: Raised to $26.00

Date: 217 days ago

Olema Pharmaceuticals is a clinical-stage biotechnology company focused on developing novel therapies for inflammatory and dermatological diseases, including psoriasis and atopic dermatitis.

Maze Therapeutics

Location: -

Funding: Raised to $36.00

Date: 228 days ago

Maze Therapeutics is a clinical-stage biotechnology company that leverages human genetics and functional genomics to discover and develop novel therapies for cardiometabolic and other diseases.

Rigel Pharmaceuticals

Location: -

Funding: Raised to $38.00

Date: 233 days ago

Rigel Pharmaceuticals is a biopharmaceutical company developing novel small molecule therapies for inflammatory diseases, immune disorders, and cancer.

Rigel Pharmaceuticals

Location: -

Funding: Raised to $38.00

Date: 233 days ago

Rigel Pharmaceuticals is a biotechnology company specializing in the discovery, development, and commercialization of small molecule therapies for immunologic, hematologic, and oncologic diseases.

Agtonomy

Location: South San Francisco, California

Website: agtonomy.com

Funding: Secures $18 M

Date: 241 days ago

Agtonomy develops AI-driven software to automate off-road vehicles in industries like agriculture and construction, enabling scalable, efficient, and reliable autonomous operation in real-world field conditions.

Vivodyne

Location: South San Francisco, CA

Website: vivodyne.com

Funding: Secures $40M

Date: 392 days ago

Vivodyne develops an AI and robotics-powered platform for human tissue testing, enabling advanced and scalable solutions for biomedical research and drug development.